Cash-pay compounded GLP-1 providers programs start around $129/month
Compounded products are not approved or verified by the FDA for safety, effectiveness, or quality
Retatrutide works by activating three hormone receptors involved in appetite control, digestion, blood sugar regulation and energy metabolism
Background One in eight adults lives with obesity, and many now use incretin drugs that can cut weight by over 20%
As a result, the plan will reduce out-of-pocket costs for eligible patients and includes introductory pricing for first-time coupon users, and grant access to the newly FDA-approved oral Wegovy pill, as an alternative to injectable treatment
Initially studied for its role in controlling blood sugar in type 2 diabetes, GLP-1 has now gained attention for its remarkable effects on weight management